BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17896396)

  • 21. Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy.
    Goudarzi B; Kishimoto R; Komatsu S; Ishikawa H; Yoshikawa K; Kandatsu S; Obata T
    Magn Reson Imaging; 2010 Apr; 28(3):372-9. PubMed ID: 20106624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-Body Diffusion Imaging Applying Simultaneous Multi-Slice Excitation.
    Kenkel D; Wurnig MC; Filli L; Ulbrich EJ; Runge VM; Beck T; Boss A
    Rofo; 2016 Apr; 188(4):381-8. PubMed ID: 26815283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-body MRI for the staging and follow-up of patients with metastasis.
    Schmidt GP; Reiser MF; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of dual-source parallel RF excitation for diffusion-weighted whole-body MR imaging with background body signal suppression at 3.0 T.
    Mürtz P; Kaschner M; Träber F; Kukuk GM; Büdenbender SM; Skowasch D; Gieseke J; Schild HH; Willinek WA
    Eur J Radiol; 2012 Nov; 81(11):3614-23. PubMed ID: 22178311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor detection by diffusion-weighted MRI and ADC-mapping--initial clinical experiences in comparison to PET-CT.
    Lichy MP; Aschoff P; Plathow C; Stemmer A; Horger W; Mueller-Horvat C; Steidle G; Horger M; Schafer J; Eschmann SM; Kiefer B; Claussen CD; Pfannenberg C; Schlemmer HP
    Invest Radiol; 2007 Sep; 42(9):605-13. PubMed ID: 17700275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body diffusion-weighted magnetic resonance imaging.
    Kwee TC; Takahara T; Ochiai R; Katahira K; Van Cauteren M; Imai Y; Nievelstein RA; Luijten PR
    Eur J Radiol; 2009 Jun; 70(3):409-17. PubMed ID: 19403255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-body diffusion-weighted MR imaging with fat suppression by using STIR: clinical utility for detection of primary malignancies in patients initially presented with metastasis.
    Liang X; Congxin W; Yi Z; Jinwen H; Chuanfu L
    Eur J Radiol; 2011 Sep; 79(3):359-62. PubMed ID: 20334989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of diffusion-weighted MRI with STIR-EPI in differential diagnosis of cervical lymph nodes].
    Zhang Y; Liang BL; Gao L; Zhong JL; Ye RX; Shen J
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):70-3. PubMed ID: 17575700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion-weighted magnetic resonance imaging of urinary epithelial cancer with upper urinary tract obstruction: preliminary results.
    Takeuchi M; Matsuzaki K; Kubo H; Nishitani H
    Acta Radiol; 2008 Dec; 49(10):1195-9. PubMed ID: 19031182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images.
    Thomson V; Pialat JB; Gay F; Coulon A; Voloch A; Granier A; Guérin JC; Viallon M; Berthezene Y
    Am J Clin Oncol; 2008 Jun; 31(3):285-92. PubMed ID: 18525309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT).
    Frericks BB; Meyer BC; Martus P; Wendt M; Wolf KJ; Wacker F
    J Magn Reson Imaging; 2008 Mar; 27(3):538-45. PubMed ID: 18224677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI.
    Low RN; Gurney J
    J Magn Reson Imaging; 2007 Apr; 25(4):848-58. PubMed ID: 17335018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body diffusion-weighted MR imaging using high b-value for malignant tumor screening: usefulness and necessity of referring to T2-weighted images and creating fusion images.
    Tsushima Y; Takano A; Taketomi-Takahashi A; Endo K
    Acad Radiol; 2007 Jun; 14(6):643-50. PubMed ID: 17502253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of diffusion-weighted imaging for the detection of colorectal cancer.
    Shinya S; Sasaki T; Nakagawa Y; Guiquing Z; Yamamoto F; Yamashita Y
    Hepatogastroenterology; 2009; 56(89):128-32. PubMed ID: 19453043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technical aspects of MR diffusion imaging of the body.
    Dietrich O; Biffar A; Baur-Melnyk A; Reiser MF
    Eur J Radiol; 2010 Dec; 76(3):314-22. PubMed ID: 20299172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
    Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
    Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-body 3D water/fat resolved continuously moving table imaging.
    Börnert P; Keupp J; Eggers H; Aldefeld B
    J Magn Reson Imaging; 2007 Mar; 25(3):660-5. PubMed ID: 17326078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.